PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia
news-medical.net,
Humanigen, Inc.today extended previously reported results by presenting additional, statistically significant hematologic…
GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
Overview of attention for article published in Blood, April 2013
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (99th percentile)
Readers on
- mendeley
- 83 Mendeley